[go: up one dir, main page]

MA38364A1 - Substituted imidazopyridazine compounds - Google Patents

Substituted imidazopyridazine compounds

Info

Publication number
MA38364A1
MA38364A1 MA38364A MA38364A MA38364A1 MA 38364 A1 MA38364 A1 MA 38364A1 MA 38364 A MA38364 A MA 38364A MA 38364 A MA38364 A MA 38364A MA 38364 A1 MA38364 A1 MA 38364A1
Authority
MA
Morocco
Prior art keywords
compounds
substituted imidazopyridazine
imidazopyridazine compounds
substituted
disorder
Prior art date
Application number
MA38364A
Other languages
French (fr)
Inventor
Gerhard Siemeister
Antje Margret Wengner
Marcus Koppitz
Ulrich Klar
Roland Neuhaus
Michael Brüning
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Priority claimed from PCT/EP2014/053573 external-priority patent/WO2014131739A2/en
Publication of MA38364A1 publication Critical patent/MA38364A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des composés imidazopyridazines substitués, des procédés de préparation desdits composés, des compositions pharmaceutiques et des combinaisons comprenant lesdits composés et l'utilisation desdits composés pour la fabrication d'une composition pharmaceutique pour le traitement ou la prophylaxie d'une maladie, en particulier un trouble hyper-prolifératif et/ou un trouble de l'angiogenèse, en tant qu'agent unique ou en combinaison avec d'autres principes actifs.The present invention relates to substituted imidazopyridazine compounds, processes for the preparation of said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular a hyper-proliferative disorder and / or a disorder of angiogenesis, as a single agent or in combination with other active ingredients.

MA38364A 2013-03-01 2014-02-25 Substituted imidazopyridazine compounds MA38364A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13157453 2013-03-01
PCT/EP2014/053573 WO2014131739A2 (en) 2013-03-01 2014-02-25 Substituted imidazopyridazines

Publications (1)

Publication Number Publication Date
MA38364A1 true MA38364A1 (en) 2018-07-31

Family

ID=47754368

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38364A MA38364A1 (en) 2013-03-01 2014-02-25 Substituted imidazopyridazine compounds

Country Status (2)

Country Link
AR (1) AR094934A1 (en)
MA (1) MA38364A1 (en)

Also Published As

Publication number Publication date
AR094934A1 (en) 2015-09-09

Similar Documents

Publication Publication Date Title
MA40523B1 (en) 2- (morpholin-4-yl) -1,7-naphthyridines
MA41135B1 (en) Substituted benzamides 1,3-thiazol-2-yl
MA35422B1 (en) Amine-substituted imidazopyridazines
MA42376B1 (en) Substituted oxopyridine derivatives
MA40893B1 (en) Hydroxyalkyl substituted phenyltriazole derivatives and uses thereof
MA35187B1 (en) Compounds having a muscarinic receptor antagonist activity and a beta2 adrenergic receptor agonist
MA34655B1 (en) AMINOALCOOL-SUBSTITUTED 2,3-DIHYDROIMIDAZO [1,2-C] QUINAZOLEIN DERIVATIVES USEFUL IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS AND ANGIOGENESIS RELATED DISEASES
MA47447A (en) 2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES FOR CANCER TREATMENT
MA45020A (en) AROMATIC SULPHONAMIDE DERIVATIVES
MA47356B1 (en) Isochromene derivatives useful as inhibitors of phosphoinositide 3-kinases
PH12020500134A1 (en) Dihydrooxadiazinones
MA40875A (en) 2,4-DIAMINO-QUINOLEIN SUBSTITUTED AS NEW ANTI-CANCER AGENTS
PH12017501133A1 (en) Pyrazolopyridinamines
UY37971A (en) SUBSTITUTED MACROCYCLIC INDOL DERITATES
WO2017198341A8 (en) Macrocyclic indole derivatives
PH12016500054A1 (en) Substituted pyrazolo-pyridinamines
MA39146A1 (en) Combinations of Gabapentanoids and Sigma Receptor Ligands
MA41174B1 (en) Imidazopyridazine derivatives used as pi3kbeta inhibitors
MA47082B1 (en) Aromatic carboxylic acid amides as bradykinin b1 receptor antagonists
MA38364A1 (en) Substituted imidazopyridazine compounds
MA43553B1 (en) 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES
MA38642A1 (en) Pharmaceutical compositions of substituted triazolopyridine compounds for use as anticancer agents
MA38774A1 (en) Substituted pyrazolo-pyridinamines inhibitors of mknk1 kinase for use in hyperproliferative and / or angiogenesis disorders.
MA39256A1 (en) Benzimidazol-2-amines as midh1 inhibitors
MA39041B1 (en) Thienopyrimidines as inhibitors of mknk1 and mknk2